14-91904797-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_006329.4(FBLN5):c.380-9725C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.433 in 152,096 control chromosomes in the GnomAD database, including 14,445 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.43 ( 14445 hom., cov: 33)
Consequence
FBLN5
NM_006329.4 intron
NM_006329.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.372
Publications
12 publications found
Genes affected
FBLN5 (HGNC:3602): (fibulin 5) The protein encoded by this gene is a secreted, extracellular matrix protein containing an Arg-Gly-Asp (RGD) motif and calcium-binding EGF-like domains. It promotes adhesion of endothelial cells through interaction of integrins and the RGD motif. It is prominently expressed in developing arteries but less so in adult vessels. However, its expression is reinduced in balloon-injured vessels and atherosclerotic lesions, notably in intimal vascular smooth muscle cells and endothelial cells. Therefore, the protein encoded by this gene may play a role in vascular development and remodeling. Defects in this gene are a cause of autosomal dominant cutis laxa, autosomal recessive cutis laxa type I (CL type I), and age-related macular degeneration type 3 (ARMD3). [provided by RefSeq, Jul 2008]
FBLN5 Gene-Disease associations (from GenCC):
- cutis laxa, autosomal dominant 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp
- cutis laxa, autosomal recessive, type 1AInheritance: SD, AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
- Charcot-Marie-Tooth disease, demyelinating, IIA 1HInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- demyelinating hereditary motor and sensory neuropathyInheritance: AD Classification: MODERATE Submitted by: ClinGen
- macular degeneration, age-related, 3Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- autosomal dominant cutis laxaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary sensorimotor neuropathy with hyperelastic skinInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- autosomal recessive cutis laxa type 1Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.454 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| FBLN5 | NM_006329.4 | c.380-9725C>T | intron_variant | Intron 4 of 10 | ENST00000342058.9 | NP_006320.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.433 AC: 65758AN: 151976Hom.: 14434 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
65758
AN:
151976
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.433 AC: 65813AN: 152096Hom.: 14445 Cov.: 33 AF XY: 0.431 AC XY: 32025AN XY: 74350 show subpopulations
GnomAD4 genome
AF:
AC:
65813
AN:
152096
Hom.:
Cov.:
33
AF XY:
AC XY:
32025
AN XY:
74350
show subpopulations
African (AFR)
AF:
AC:
19040
AN:
41470
American (AMR)
AF:
AC:
6418
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
AC:
1617
AN:
3470
East Asian (EAS)
AF:
AC:
1193
AN:
5174
South Asian (SAS)
AF:
AC:
1804
AN:
4820
European-Finnish (FIN)
AF:
AC:
4558
AN:
10582
Middle Eastern (MID)
AF:
AC:
172
AN:
294
European-Non Finnish (NFE)
AF:
AC:
29493
AN:
67972
Other (OTH)
AF:
AC:
992
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1962
3924
5885
7847
9809
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
618
1236
1854
2472
3090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1203
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.